Biograil
Swallowable capsule device for oral delivery of injectable drugs
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Biograil is a Copenhagen-based biotech company developing pharmaceutical products based on its BIONDD device, which sits inside a standard-size capsule and delivers therapeutics that would otherwise be injected into the stomach mucosal wall for systemic absorption. In November 2026 it announced a €20 million financing round backed by Verve Ventures and Megatrend Invest, with HTGF participating, to prepare BIONDD for phase 1 clinical testing.
- Website
- biograil.com
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- BIONDD — Capsule device that delivers injectable drugs orally via the stomach wall · Hardware